Your browser doesn't support javascript.
loading
Deficiency of two-pore segment channel 2 contributes to systemic lupus erythematosus via regulation of apoptosis and cell cycle.
Li, Keke; Xu, Jingkai; Xue, Ke; Yu, Ruixing; Li, Chengxu; Fei, Wenmin; Ning, Xiaoli; Han, Yang; Wang, Ziyi; Shu, Jun; Cui, Yong.
Afiliação
  • Li K; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Xu J; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Xue K; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Yu R; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Li C; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Fei W; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Ning X; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Han Y; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Wang Z; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Shu J; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Cui Y; Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
Chin Med J (Engl) ; 135(4): 447-455, 2022 Jan 12.
Article em En | MEDLINE | ID: mdl-35194006
BACKGROUND: Systemic lupus erythematosus (SLE) is a complex autoimmune disease, and the mechanism of SLE is yet to be fully elucidated. The aim of this study was to explore the role of two-pore segment channel 2 (TPCN2) in SLE pathogenesis. METHODS: Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression of TPCN2 in SLE. We performed a loss-of-function assay by lentiviral construct in Jurkat and THP-1 cell. Knockdown of TPCN2 were confirmed at the RNA level by qRT-PCR and protein level by Western blotting. Cell Count Kit-8 and flow cytometry were used to analyze the cell proliferation, apoptosis, and cell cycle of TPCN2-deficient cells. In addition, gene expression profile of TPCN2-deficient cells was analyzed by RNA sequencing (RNA-seq). RESULTS: TPCN2 knockdown with short hairpin RNA (shRNA)-mediated lentiviruses inhibited cell proliferation, and induced apoptosis and cell-cycle arrest of G2/M phase in both Jurkat and THP-1 cells. We analyzed the transcriptome of knockdown-TPCN2-Jurkat cells, and screened the differential genes, which were enriched for the G2/M checkpoint, complement, and interleukin-6-Janus kinase-signal transducer and activator of transcription pathways, as well as changes in levels of forkhead box O, phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin, and T cell receptor pathways; moreover, TPCN2 significantly influenced cellular processes and biological regulation. CONCLUSION: TPCN2 might be a potential protective factor against SLE.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article